[Febrile neutropenia in pediatric and adolescent cancer patients]
- PMID: 33746294
- PMCID: PMC7959272
- DOI: 10.1007/s00112-021-01146-4
[Febrile neutropenia in pediatric and adolescent cancer patients]
Abstract
Febrile neutropenia is the most common potential emergency situation in children and adolescents with cancer. The host response of these patients is severely compromised by treatment-induced immunosuppression resulting in a lack of important defence mechanisms, so that bacterial infections and in certain risk groups also fungal infections can be life threatening. As the clinical course of these infectious complications may be rapid and fatal, early antibiotic treatment can save lives. This article aims to raise awareness to this emergency situation and gives an overview of the management of pediatric cancer patients with febrile neutropenia.
Fieber während der Granulozytopenie („febrile neutropenia“) ist die häufigste potenzielle Notfallsituation in der Kinderonkologie. Aufgrund der therapiebedingten Immunsuppression fehlen dem Patienten wichtige Abwehrmechanismen, sodass v. a. bakterielle Infektionen und in bestimmten Risikogruppen auch Pilzinfektionen lebensbedrohlich verlaufen können. Die möglichst zeitnahe Einleitung einer angemessenen antibiotischen Therapie kann hier Leben retten. Der vorliegende Beitrag möchte für diese Notfallsituation sensibilisieren und einen Überblick über das Management dieser Patienten geben.
Keywords: Antibiotics; Bacterial infections; Emergencies; Fungal infections; Immune system.
© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021.
References
-
- Alali M, David MZ, Danziger-Isakov LA, Bartlett AH, Petty LA, Schwartz T, Pisano J. Association between depth of neutropenia and clinical outcomes in febrile pediatric cancer and/or patients undergoing hematopoietic stem-cell transplantation. Pediatr Infect Dis J. 2020;39:628–633. doi: 10.1097/INF.0000000000002641. - DOI - PubMed
-
- Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M, ECIL4. EBMT. EORTC. ICHS. ESGICH/ESCMID. ELN European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013;98:1826–1835. doi: 10.3324/haematol.2013.091025. - DOI - PMC - PubMed
-
- Bochennek K, Hassler A, Perner C, Gilfert J, Schöning S, Klingebiel T, Reinhardt D, Creutzig U, Lehrnbecher T. Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004. Blood Cancer J. 2016;6:e382. doi: 10.1038/bcj.2015.110. - DOI - PMC - PubMed
-
- Cohen C, King A, Lin CP, Friedman GK, Monroe K, Kutny M. Protocol for reducing time to antibiotics in pediatric patients presenting to an emergency department with fever and neutropenia efficacy and barriers. Pediatr Emerg Care. 2016;32:739–745. doi: 10.1097/PEC.0000000000000362. - DOI - PMC - PubMed
-
- Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 2004;22:4384–4393. doi: 10.1200/JCO.2004.01.191. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources